|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 SEK | -3.47% |
|
-5.30% | +35.14% |
| 07-20 | Biovica International AB Receives First Work Order Under Expanded Master Services Agreement with Global Pharmaceutical Company | CI |
| 07-20 | Biovica Secures SEK1 Million Oncology Study Work Order | MT |
| Market Cap | 146M 15.3M 13.3M 12.38M 11.37M 21.47M 1.46B 21.8M 57.28M 727M 57.47M 56.21M 2.44B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 146M 15.3M 13.3M 12.38M 11.37M 21.47M 1.46B 21.8M 57.28M 727M 57.47M 56.21M 2.44B | EV / Sales 2027 * |
5.68x | EV / Sales 2028 * | 3.15x |
| Free-Float |
97.19% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Biovica International AB
| 1 day | -3.47% | ||
| 1 week | -5.30% | ||
| 1 month | +38.89% | ||
| 3 months | +42.86% | ||
| 6 months | +12.87% | ||
| Current year | +35.14% |
| 1 week | 0.47 |  | 0.57 |
| 1 month | 0.35 | | 0.57 |
| Current year | 0.27 | | 0.57 |
| 1 year | 0.27 | | 0.72 |
| 3 years | 0.27 | | 10.36 |
| 5 years | 0.27 | | 66.3 |
| 10 years | 0.27 | | 69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theis Kipling
CEO | Chief Executive Officer | 44 | 2026-04-30 |
Anders Morén
DFI | Director of Finance/CFO | 61 | 2022-12-31 |
Hanna Ritzen
COO | Chief Operating Officer | 47 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anders Rylander
BRD | Director/Board Member | 56 | 2009-12-31 |
Maria Holmlund
BRD | Director/Board Member | 70 | 2015-12-31 |
| Director/Board Member | 60 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/25 | Buy | Director | 1,871,925 | 2.2265% | ||
| 12/20/23 | Buy | Executive/Senior Manager | 1,700 | 0.0040% | ||
| 8/24/22 | Others | Director | 46,700 | 0.2135% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.47% | -5.30% | -24.01% | -94.10% | 15.3M | |
| -22.52% | -18.18% | +97.02% | +68.74% | 3.69B | |
| -6.66% | +1.35% | +120.41% | +167.42% | 3.59B | |
| -13.22% | -18.44% | +58.37% | -43.94% | 1.82B | |
| +3.44% | +4.55% | -28.26% | -36.48% | 2.17B | |
| +14.72% | +17.69% | +255.80% | +300.64% | 2.26B | |
| -2.67% | -2.81% | +180.77% | -41.91% | 969M | |
| +6.96% | -1.82% | -9.43% | +15.45% | 853M | |
| +1.29% | +6.41% | -37.76% | -14.48% | 511M | |
| +7.90% | -3.22% | -2.47% | - | 449M | |
| Average | -1.42% | -3.10% | +61.04% | +35.70% | 1.63B | |
| Weighted average by Cap. | -5.07% | -3.69% | +95.52% | +84.32% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 25.7M 2.69M 2.34M 2.18M 2M 3.78M 257M 3.84M 10.09M 128M 10.12M 9.9M 429M | 46.3M 4.85M 4.22M 3.93M 3.61M 6.81M 463M 6.92M 18.17M 231M 18.23M 17.83M 774M |
| Net income | -59.4M -6.23M -5.41M -5.04M -4.63M -8.74M -595M -8.87M -23.31M -296M -23.39M -22.88M -992M | -33.4M -3.5M -3.04M -2.83M -2.6M -4.91M -334M -4.99M -13.11M -166M -13.15M -12.86M -558M |
| Net Debt | - | - |
Employees
25
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | SEK 0.5000 | -3.47% | 273,628 |
| 26-07-30 | SEK 0.5180 | +4.23% | 304,526 |
| 26-07-29 | SEK 0.4970 | -0.60% | 552,707 |
| 26-07-28 | SEK 0.5000 | -7.41% | 644,608 |
| 26-07-27 | SEK 0.5400 | +2.27% | 1,400,945 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIOVIC B Stock
Select your edition
All financial news and data tailored to specific country editions
